To better understand the mechanisms underlying this, we compared patients with high B and T cell tumour infiltrate proportions (as a percentage of CD45+ cells), termed adaptive-enriched (AE) versus high myeloid, low B and T cell proportions, termed myeloid-enriched (ME) (Fig. 1d, e). Here, PTPRC is linked to neoplasm.